A Waukesha County deputy is battling a "rare, aggressive cancer." Steve Lyles has been with the department for nearly 20 ...

Metastatic papillary renal cancer has poor outcomes, and new treatments are needed. There is a strong rationale for investigating the combination of mesenchymal epithelial transition receptor (MET) ...

The combination of savolitinib and durvalumab demonstrated durable activity in a phase 2 trial of patients with papillary RCC.

Due to the ongoing shortage of BCG, gemcitabine has been increasingly used for first-line NMIBC therapy. N-803’s ability to activate natural killer and CD8+ T cells, thus the innate immune system, to ...

Renal cell carcinoma (RCC) refers to a heterogenous ... The three most common forms of RCC are clear cell RCC, papillary RCC and chromophobe RCC. This study challenges the idea that KDM5D in ...

ImmunityBio (IBRX) announced the Medicines and Healthcare products Regulatory Agency has validated and accepted the marketing authorization ...

Ferring Pharmaceuticals announced today three abstracts featuring ADSTILADRIN® (nadofaragene firadenovec-vncg) will be presented at the 2025 American Society of Clinical Oncologists Genitourinary ...

Objective: To characterize and further compare the immune cell populations of the tumor microenvironment (TME) in both clear cell and papillary renal cell carcinoma (RCC) using heavy metal-labeled ...

Inflammation within intraductal papillary mucinous neoplasms (IPMNs ... as well as 42 patients who had invasive carcinoma within the IPMN. We also included 21 patients with other cystic pancreatic ...

3 Graduate School of Public Health, St Luke’s International University, Tokyo, Japan Objective Current guidelines recommend long-term image-based surveillance for patients with low-risk intraductal ...

There is a description of a horseshoe vascular pattern, which was not observed in the present case. 3, 5 SCAP can infect, bleed, ulcerate, and, in rare cases, it can progress to basal cell carcinoma ...